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Abstractd 
 
During the last thirty years health care expenditure (HCE) has been growing much more rapidly 
than GDP in all OECD countries. Against this background, we look at the determinants of HCE 
growth in Europe, explicitly taking into account the role of income, ageing population, life 
habits, technological progress, as well as institutional and budgetary variables. Our results 
confirm that the current trend of increasing HCE is rooted in a set of differentiated factors. 
Income levels lead to higher HCE, and the magnitude of the estimated elasticity poses serious 
concerns about long-term sustainability of current trends. All in all, HCE growth appears to be 
driven by structural factors that cannot be easily compressed if not through rationing. The key 
challenge for many European Governments seems to be the design of pluralistic systems, where 
a well-balanced mix of public and private financing can realize a balance between sustainability 
and access. 
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I. Introduction 
During the last thirty years health care expenditure (HCE) has been growing much 
more rapidly than GDP in all OECD countries. All major players in the field, 
including the OECD and the European Commission (Working Group on Ageing 
Population – AWG), pose serious concerns about long-term sustainability of 
current trends.  
Since the seminal works of Baumol (1967) and Newhouse (1977, 1992), the 
availability of international data on HCE has encouraged the development of 
several studies that have attempted to explain the trend and determinants of HCE 
growth. A wide array of factors has been taken into consideration, including 
demography, income, institutions, technological change (Gerdtham and Jönsson, 
2000).  
Not surprisingly, income is the prominent factor behind cross-country differentials 
in HCE. The magnitude of income elasticity is key to ascertain whether health is a 
luxury good (income elasticity above one) or a necessity (income elasticity below 
one). Unfortunately, this issue is largely unresolved, and empirical investigations 
which rely on different data, time frames and methodologies have come to 
conflicting results. Moreover, it has been noticed that income elasticity of health 
spending increases with the level of aggregation (see Dormont et al., 2007). 
Demography, institutions and technology have been identified as important 
drivers of the rising HCE too. However, on the empirical ground, being them 
tightly interwoven, it has been extremely difficult to single out their specific 
contribution. 
The relationship between age and HCE has been largely explored by the empirical 
literature. Nonetheless, previous studies relying on the composition of the 
population in terms of age cohorts to measure the effect of an ageing population 
have come to conflicting results (see Christiansen et al., 2006 for a review). As a 
tentative explanation, micro-level studies have shown that it is not age per se that 
is relevant in explaining HCE, rather remaining lifetime. Accordingly, we focus 
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on increase in life expectancy and on decrease in fertility rates (see Zweifel et al., 
1999). 
In this paper we present an exploratory econometric framework aimed at 
identifying the determinants of HCE growth and at estimating the elasticity of 
HCE to income growth in European countries. We take into account the effect of 
ageing population, technological progress, as well as institutional and budgetary 
variables. We perform separate econometric analysis of the level of total, private 
and public HCE. Our study casts new light on the effect of the adoption and 
diffusion of new technologies and practices in national specific institutional 
settings, as well as on the impact of budgetary controls and constraints upon 
overall European HCE.  
The paper is organized as follows. The next section describes the data and the 
hypothesis underlying the explanatory variables included in the analysis. Section 
III describes the methodology and reports the results of our analysis. Section IV 
concludes, discussing the main policy implications of our work. 
 
II. Data sources and model specification 
The paper aims at disentangling the key drivers of long-term HCE in Europe.  
We estimate a set of equations in a panel of EU-15 Countries5 for the period 
1980-2003. .  
Different equations are estimated for: a) total health care expenditure (THE); b) 
public health care expenditure (PHE); c) private health care expenditure (PrHE)6. 
We collected and integrated data from several sources ranging from OECD and 
WHO to PubMed and Eurostat. Data on HCE come from the OECD Health Data 
                                                 
5
 Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, 
Netherlands, Portugal, Spain, Sweden, and United Kingdom. 
6
 PrHE is obtained as the difference between THE and PHE. 
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(OECD, 2007) and the WHO’s “European Health for All” databases (WHO, 
2006). Only current expenditure has been considered in the analysis7. 
Different regression settings have been designed to identify and compare key 
drivers of total, public and private HCE. Five explanatory factors have been taken 
into account: national income (GDP), ageing of the population, technological 
progress, institutional and regulatory variables, composition of the welfare system 
and of public budget, life habits. 
Different methodologies have been applied to deal with the different patterns of 
series stationarity, endogeneity of GDP, and the “small-N” characteristic of our 
dataset. We take into account the relationship between per capita HCE (THE, 
PHE, PrHE) and per capita GDP. Endogeneity of GDP is taken into account by 
considering a two-stage regression approach. Then, we estimate the relationship 
between HCE and ageing of the population, technological progress, institutional 
framework, as well as Government budget variables and life habits. When 
feasible, the pooled mean group (PMG) estimator proposed by Pesaran, Shin, and 
Smith (1999) is applied in order to estimate long-run elasticities, allowing short-
run coefficients and error variances to differ across countries. Otherwise a country 
fixed effect regression is considered. Different methodologies complement each 
other allowing us to assess the impact of the different regressors on the level of 
expenditure. 
 
a. Income 
Since Baumol (1967), most studies have documented a positive relation between 
GDP and HCE. However, as stressed by Hartwig (2008), the evidence of a 
correlation between HCE and GDP does not tell much about any clear causal 
relationship. It can be argued that he higher HCE, the healthier the population. At 
the same time, a healthier population is likely to be more productive and GDP per 
                                                 
7
 Values have been converted into PPP US dollars, and the GDP deflator has been applied to obtain real 
values. Log-values (natural) have been used for all regressed variables but the dummy variables 
describing the institutional framework and the time trend. 
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capita could grow as an effect of an increase in HCE. If this effect is not taken 
into account, econometric techniques can lead to biased and inconsistent results. 
Even though little attention has been devoted to this issue in the empirical 
literature, income elasticity of health care demand and expenditure lies at the heart 
of a lively debate, focusing on whether health care is a “luxury good” in 
developed countries. The answer has important policy implications for HCE 
growth and public finances sustainability. 
Some recent contributions (see Hall and Jones, 2007) point to the fact that health 
spending might well be a superior good, since it allows individuals to live longer 
and “purchase” additional periods of life and utility. Within this framework, in 
any period of time, people do not become saturated with health consumption, as it 
happens with non-health consumption. As income grows and people get richer, 
the most rewarding channel for spending is to purchase additional years of life 
(and consumption). As a result, the optimal composition of total spending shifts 
toward health, and health expenditure share grows along with income.  
Empirically, health care spending might not represent optimal consumption, due 
to exogenous Government regulation that limits the choices of patients and 
aggregate HCE mainly for equity and budget control purposes. For this reason, we 
are not allowed to infer the “luxury good” versus “normal good” nature of health 
care from our estimates on income elasticity of public health expenditure. 
 
b. Ageing population 
Over the last decades developed countries have experienced a marked change in 
the age composition of population. The share of elderly people has increased, as a 
consequence of lower fertility rates and of higher life expectancy, due to 
improved living condition and medical progress. This trend is deemed to continue 
over the next decades. The impact of population ageing on the social structure and 
on the long-term sustainability of public finances is one of the main challenges for 
Europe in the upcoming years. 
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Ageing is placing an increasing burden on health care systems. The health care of 
the elderly is financed by those in work, and demographic change means that a 
smaller proportion of the population is in working age. The difficulties will be 
more pronounced in tax-based, pay as you go (Paygo) systems, but all health care 
systems are facing this issue. 
In addition, ageing will push health spending up, since the elderly make a higher 
use of health care services, and individual health care costs tend to rise with age. 
This effect might be mitigated or offset by the fact that over time longevity gains 
correspond to more years in good health. This “healthy ageing” component tends 
to lower the average cost per individual at any older age, and in this scenario 
aggregate HCE will not necessarily increase with an ageing population. 
In line with these arguments, most empirical studies in a static framework have 
shown a positive relationship between age, ageing and health expenditures; while 
a dynamic assessment, using time series or panel data, provides mixed evidence 
about the sign and significance of this relationship, reflecting the interplay of the 
different determinants (see Christiansen et al., 2006 for a review).  
In order to account for the impact of demographic changes and ageing, we 
introduce two variables: life expectancy at age 65 (LEXP65)8, and fertility rate 
(FERTILITY).. 
 
c. Technological innovation 
Technological innovation in medicine includes not only new physical capital and 
equipment, but also new surgical procedures, drugs, treatments, as well new 
procedures based on original combinations of the above. Analogously to the 
expected effect of the ageing population, economic theory does not predict a 
                                                 
8
 Increase in life expectancy lies at the root of the ageing population, leading us to expect a positive sign 
of its estimated coefficient. Nonetheless it can be argued that gains in life expectancy are largely driven 
by medical progresses, making LEXP65 also suited as a proxy for technological advances. However, by 
using LEXP65, we aim at capturing the effect of age on HCE, rather than the effect of technological 
advances. In order to disentangle both effects, besides the use of “technological innovation” variables, as 
described in the next section, all regressions will include a linear time trend that will capture the effect of 
unmeasured variables linearly evolving over time.  
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clear-cut effect of technological innovation on health care costs and expenditure: 
new technologies can reduce unitary costs, but there are factors that can offset the 
savings and induce an increase in aggregate health expenditure, such as the 
increasing number of applications and indications, the higher number of treatable 
conditions, the increase in the rate of use for the same condition, and the 
broadening of the definition of “disease” (Gelijns and Rosenberg, 1994). As a 
result of these contrasting effects, medical innovations which are cost reducing at 
the micro level can lead to an increase in overall aggregate expenditure. Indeed, 
available empirical evidence consistently shows that new medical technologies 
are a major determinant of the rise of health care expenditure (see Pammolli et al., 
2005 for a review).  
Empirical evaluation of the impact of technological innovation is restrained by the 
complexity in measuring technological change, as well as its direct and indirect 
effects. Studies at the macro level generally deduce the effect of technological 
change as the “residual” increase in expenditure not explained by the interplay of 
demographic change and GDP growth assuming unitary income elasticity. On a 
different ground, applied work has proxied the extent of medical technology 
adoption in a given country by the stock of available high-tech medical devices, 
such as magnetic resonance equipment, or medical practices based on high-tech 
equipments, e.g. patients undergoing dialysis (see Christiansen et al., 2006). 
Under the assumption that technological progress deploys its effect linearly over 
time, other studies represent technological change as a linear time trend 
(Blomqvist and Carter, 1997; Zweifel et al., 1999). Alternatively, measures of 
innovation input (such as research and development expenditure, or employees) or 
output (i.e. patent counts, patent citations…) can be employed (see Jaffe, 
Trajtenberg, 2002). 
Available time series of data on medical technology equipment stock and usage 
are severely incomplete, and thus unsuitable for this study. However, 
technological progress spills over institutional and national boundaries and 
diffuses across institutions and countries leveling off productivity and innovation 
differentials. Accordingly, we consider the number of scientific publications in 
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areas related to the assessment of new medical technologies, as a proxy for 
technological adoption. We rely on this indicator rather than on patent statistics 
since innovation in this field is mostly related to the exploitation of existing 
medical technologies. This likely does not lead to a patentable claim, rather to a 
scientific publication. Our variable, “Number of publications per 1,000 
inhabitants” (TECH_AD) comes from the PubMed database, that we queried for 
publications on “Equipment and Supplies” and “Surgical procedure, operative” in 
the countries and time periods considered in the analysis9 to proxy the extent of 
informed adoption of medical technologies . 
We also consider the number of death associated with pathologies treated with 
high-tech devices, focusing on coronary diseases. Ford et al. (2007) show that 
improvements in medical treatments accounted for approximately 47% of the 
decrease in mortality rate due to coronary diseases. The wider the adoption of 
high-tech devices, the lower the mortality rate. Therefore, we take the number of 
deaths caused by coronary diseases as a proxy for technological adoption10. 
Contrary to TECH_AD, this variable captures the cost-enhancing effect of 
medical technologies through an increase of individual life expectancy. This 
effect has been rigorously documented by a series of highly influential recent 
contributions (Murphy and Topel, 2003; Lichtenberg, 2007). 
Given the multi-facet characteristics of the innovation process in health, we are 
aware of the fact that our proxies imperfectly capture the effect of technological 
advances. Even though imperfectly measured, our analysis will allow us to 
empirically assess the effect of technological change on HCE. 
 
                                                 
9
 PubMed is a service maintained by the US National Library of Medicine, covering over 17 million 
citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. 
10
 In previous versions of the model, we also considered deaths due to diabetes mellitus, but the effect of 
this variable was not statistically significant. Moreover, contrary to cardiovascular deaths, available 
information does not allow us to interpret the dynamics in diabetes mellitus deaths as a function of the 
adoption of new technologies. Therefore, the variable has been removed from the analysis. 
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d. Life habits 
Life habits are among the most important determinants of the health status of a 
population, and therefore deeply linked to HCE. In our regressions we attempt at 
measuring life habits by considering per capita consumption of sugar (SUGAR) 
and fruits and vegetables (FVEG) in kilos, extracted from OECD Health Data. To 
our knowledge, only the study by Christiansen et al. (2006) takes behavioral 
variables into account when analyzing the determinants of HCE. The authors 
consider alcohol and tobacco consumption. However, series for alcohol and 
tobacco are largely incomplete and we chose to use sugar and fruits and 
vegetables consumption with a lower incidence of missing cases. Tightly linked to 
problems of obesity and cardiovascular diseases, we expect the sugar 
consumption to positively affect HCE, whereas we expect a negative effect of the 
consumption of fruit and vegetables11.  
 
e. Institutional and regulatory framework 
We account for the institutional and regulatory features of the EU health systems 
by means of a set of dummies. 
The first dummy variable (GATE) controls for the General Practitioners (GP) 
gatekeeper role, that is to say the GP refers patients to in-patient hospital care 
(Christiansen et al. 2006). Even in the presence of a significant cross-country and 
within-country heterogeneity in ambulatory care organization and financing (see 
Docteur, Oxley, 2003), countries where GPs play as gatekeepers are expected to 
register lower health expenditure, ceteris paribus, given that ambulatory care is 
generally less expensive than hospital care.  
The dummy variable COPAY is included for countries that adopt a co-payment 
system for hospital inpatient12 (see Docteur & Oxley 2003, Christiansen et al., 
                                                 
11
 Luxembourg,has been omitted from the analysis when life habits are included in the regressions due to 
missing data. 
12
 Since it has not been possible to collect data on the exact level of cost sharing, the co-payment dummy 
variable is only a crude indication for restriction in consumption induced by patient contribution to health 
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2006). A negative sign is expected, since co-payment could contain HCE, by 
stimulating an efficient access to medical facilities therefore decreasing the impact 
of non-necessary access. However, since co-payment schemes have been 
generally introduced in Europe to contain HCE growth, determinants and 
consequences of these measures are hard to disentangle. 
On a different ground, it is important to control for the substitution effect between 
informal and formal assistance due to the increase of female labor participation 
rate. Indeed, the participation of women to the labor force implies a substitution 
between informal and formal health care and presumably an increase in aggregate 
health expenditure. The female labor participation rate is included among the 
explanatory variables to account for this effect. On the one hand, a positive 
coefficient should pose additional concern on the sustainability of current HCE 
trends. On the other hand, it should be noticed that, as argued by Freeman and 
Schettkat (2005) and Rogerson (2006, 2007), a higher female participation in the 
service economy and formal assistance is key to GDP growth in Europe and to the 
development of a complementary private health care sector. 
 
f. Public budget variables 
We include a set of variables aimed at capturing public budget constraints and 
characteristics that are expected to affect Governments’ attempts and policies to 
curb expenditure, in order to pursue long-term sustainability of public finances. 
To our knowledge, no previous empirical account of the determinants of HCE has 
taken into account budget variables; nonetheless these are likely to exert strong 
constraints on public expenditure (Gerdtham and Jönsson, 2000). Implementing a 
durable budgetary reform requires the reduction of the budget deficit and of the 
debt to GDP ratio. Since budgetary variable are deeply intertwined, only the 
public debt to GDP ratio (DEBT/GDP) is included in the regressions.  
                                                                                                                                              
care costs. We do not discern among different co-payment schemes: fixed-fee co-payment, co-payment as 
a share of expenditure, co-payment as a function of patient income. 
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We also take into account the structure of social expenditure by considering a 
concentration index computed on the basis of the resources allocated to main 
social policy areas13. EU-15 countries are largely diversified in terms of the 
structure of social expenditure, as shown in Figure 1, which reports the share of 
expenditure in the main social policy areas considered over GDP in the year 2003. 
The larger share of resources is devoted to old age benefits, followed by social 
expenditure for health. The share of resources devoted to the other policy areas 
vary widely across countries. 
 
// FIGURE 1 ABOUT HERE: Main policy areas, % GDP, 2003 (Source: OECD, 
2007) // 
 
We use the Herfindahl index to measure the level of concentration of social 
expenditure14. Two versions of the index are computed: the first one takes into 
account all main policy areas; the second one excludes the resources devoted to 
health from computations15. 
Two contrasting effects can be captured by the variable. First, as a result of a 
substitution effect, lower expenditure in pensions and other policy areas can lead 
to increases in HCE (under budget constraints, lower resources devoted to one 
area makes larger resources available for other policy items). We argue that this is 
not the main effect that the variable is able to capture. Indeed, by including the 
variable in the regressions we aim at measuring the gains in efficiency spanning 
from a wider coverage of the social expenditure and improved social and market 
                                                 
13
 We considered aggregations as reported in OECD data: (i) pensions and services for the elderly; (ii) 
pensions and services for survivors; (iii) health; (iv) incapacity-related benefits; (v) family support; (vi) 
active labor market policies; (vii) unemployment; (viii) housing allowances and rent subsidies; (ix) and a 
residual category (other social policy areas). 
14
 The index is computed as the sum of the shares (squared) of expenditure in all the areas considered. 
When all areas are included in computations, the index takes values between 1/9 (if all social policy areas 
have the same allocated resources) to 1 (when only one area exhibits a positive allocation, whereas all the 
other areas have an allocation equal to zero). 
15
 In this case, the Herfindahl index ranges from 1/8 to 1. As, excluding health, about one half of 
resources are devoted to old age and survivors benefits, a higher value of the Herfindahl means more 
concentration on expenditure for pensions. 
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labor conditions, promoting endogenous economic growth and opening the 
possibility for higher HCE without compromising financial sustainability16. 
Second, a well articulated welfare system (promoting labor participation and 
effective employment, and targeted to contrast poverty/needs) can help enhancing 
the conditions of the population, and preventing the worsening of the health status 
and the incidence of illnesses and pathologies. This effect can coexist with the 
ones previously described, allowing to devote more resources to the unhealthy 
part of the population, and to enlarge the possibility of treatment with the best 
available techniques. Though there is not a foreseeable physiologic upper bound 
to demand for care, unlimited spending will never be an option; and the optimal 
design for welfare system is at the core of the possibility to find the most 
appropriate balance between the goal of sustainability and that of social equity 
and technological adequacy of treatments. 
As a preliminary support to our claims, Table 1 analyzes the correlation between 
the measure of expenditure concentration and (a) deficit and (b) GDP growth17. 
Table 1(a) reports the correlation coefficients from the year 1995, between the 
deficit of a country and the level of concentration of social expenditure. We 
consider both versions of the Herfindahl index. The deficit (measured as share of 
GDP) can assume both positive and negative values, where negative values 
indicate a positive Government balance. A positive correlation emerges in recent 
years, where countries with less concentrated social expenditure also exhibits 
lower deficit, supporting the view that wider dispersion of welfare expenditure is 
associated with improved labor and social conditions, therefore allowing a 
reduction of public deficit in the long run.  
Table 1(b) shows that the correlation coefficient between real GDP growth18 and 
the level of concentration of public expenditure is always negative over the period 
                                                 
16
 Either a minor incidence on GDP for a given level of expenditure, or a higher expenditure 
corresponding to the initial incidence on GDP, or even a sustainable higher incidence of expenditure on 
GDP (see, for example, the case of Sweden, where the high quality level of social expenditure allows to 
sustain the highest share of expenditure on GDP in EU-15; see Figure 1). 
17
 The years included in Table 1 are chosen on the basis of data availability. Correlations are reported for 
the years when at least 13 countries are observed. 
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1986-2003, and in seven years significant at the 5 per cent level. Though the 
relationship deserves further investigation, the negative sign suggests that a 
diversified welfare system fosters economic growth. 
 
 
Table 1. Correlation coefficients between social expenditure concentration 
(CONC) and (a) of deficit (% GDP); (b) GDP growth  
(a) CONC and deficit (% GDP) 
 1995 1996 1997 1998 1999 2000 2001 2002 2003 
Including  
Health -0.0524 0.4170 0.1957 0.5226 0.6165* 0.4949 0.6568* 0.5413* 0.5934* 
Excluding  
Health -0.0270 0.4397 0.2411 0.5695* 0.6324* 0.4804 0.6556* 0.5421* 0.5949* 
(b) CONC and GDP growth 
 1986 1987 1988 1989 1990 1991 1992 1993 1994 
Including  
Health -0.4372 -0.6764* -0.5910* -0.4203 -0.6028* -0.4321 -0.3751 -0.6103* -0.7622* 
Excluding  
Health -0.4357 -0.6866* -0.5857* -0.3920 -0.5749* -0.4265 -0.3541 -0.6063* -0.7700* 
 1995 1996 1997 1998 1999 2000 2001 2002 2003 
Including  
Health -0.7176* -0.7704* -0.6784* -0.2761 -0.1139   -0.1561 -0.0726 0.2043 -0.0235   
Excluding  
Health -0.7640* -0.7991* -0.7217* -0.2612 -0.1126 -0.1530 -0.0760 0.1502 -0.0482    
Note: * statistically significant at 5% level  
 
III. Methodology and Results 
In line with previous work in this field (e.g. Christiansen et al., 2006; Dormont et 
al., 2007), we perform a set of exploratory econometric tests aimed at identifying 
the factors affecting the level of (per capita) HCE. In particular, we aim at 
ascertaining the impact of six categories of variables on total, private and public 
HCE: income, ageing, technology, institutional framework, budget constraints, 
and health habits. Table 2 summarizes the main descriptive statistics of the 
variables included in our regressions.  
                                                                                                                                              
18
 The growth rate of real GDP is computed between period t and t+1, while the variable CONC refers to 
year t. For example the column “1996” in Table 1(b) reports the correlation between the rate of growth of 
GDP over the years 1995-1996 and the level of concentration in 1995. 
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Table 2. Descriptive Statistics, EU-15 countries, wider coverage corresponds 
to the period 1980-2003 
 Obs Mean S.E. Min. Max. 
Dependent variables 
THE (log of total health care expenditure, deflated) 337 7.36 0.29 6.73 8.42 
PHE (log of public health care expenditure, deflated) 321 7.08 0.35 6.29 8.07 
PrHE (log of private health care expenditure, deflated) 321 5.82 0.49 4.28 7.61 
Independent variables      
a) Income/Wealth 
GDP (log of the Gross Domestic Product, deflated) 360 9.95 0.27 9.36 11.14 
b) Ageing 
LEXP65 (log of life expectancy at age 65) 340 2.83 0.07 2.64 2.97 
FERTILITY (log of fertility rate)  360 0.47 0.16 0.15 1.18 
c) Technological progress 
TECH_AD (log of number of publications per 1,000 
inhabitants in selected applied research fields) 360 -4.35 2.24 -11.02 -1.96 
DCIRC (log of circulatory disease death over 1,000,000 
population) 348 5.75 0.26 5.01 6.30 
d) Life habits      
SUGAR (log of per capita consumption of sugar, kilos) 336 3.67 0.18 3.21 4.09 
FVEG (log of per capita consumption of fruits and 
vegetables, kilos) 336 5.32 0.33 4.67 6.14 
e) Health care cost control and institutions 
GATE (equals 1 if GPs play a gatekeeper role) 360 0.17 0.37 0.00 1.00 
COPAY (equals 1 if co-payment schemes are in place) 360 0.11 0.31 0.00 1.00 
FLPR (log of female labor participation rate) 360 4.02 0.22 3.47 4.41 
f) Budgetary variables 
DEBT/GDP (log of debt to GDP ratio) 261 4.05 0.55 2.07 4.94 
CONC (log of Herfindahl index of concentration of social 
expenditure) 310 -1.30 0.30 -1.83 -0.62 
 
Given the panel structure of our data, country-specific fixed effects are included 
to control for time-invariant country characteristics which are not (or cannot be) 
observed. On the contrary, time effects are captured with the inclusion of a linear 
trend. 
A set of test for stationarity of the variables has been conducted country by 
country19. For most series the hypothesis of trend stationarity is not rejected in our 
                                                 
19
 We jointly considered the KPSS test where the null hypothesis is that the series are level/trend-
stationary, and the (augmented) Dickey-Fuller and Phillips-Perron tests where the null hypothesis is that 
the series exhibits a unit root. 
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data, the only exception being the GDP series20. In order to tackle this issue and 
avoid spurious results, we apply different methodologies.  
Whenever available data allow us, the PMG estimator is applied. The estimator 
constraints the long-run coefficient to be identical, while allowing for differences 
among short-run coefficients and error variances of different countries. The 
method can be applied both to I(0) or I(1) regressors, but the number of 
observations available for each country must be large enough to estimate the 
model for each country separately (Pesaran, Shin, Smith, 1999). Therefore, we are 
not able to estimate the “full” model by PMG, rather the demographic and 
technological change variables, and the female participation rate are added 
separately to the regressions in order to investigate the effect of the inclusion on 
the magnitude and significance of the GDP coefficient. Missing data on 
DEBT/GDP and CONC prevent us to include these variables in the analysis. In 
addition PMG estimation is not feasible when considering the institutional dummy 
variables (COPAY and GATE). In order to assess the effect of these variables a 
fixed effect regression is undertaken, where first differenced variables have been 
considered in the analysis. Differently from previous studies (see e.g. Dormont et 
al., 2007), we explicitly consider the possibility of endogeneity of the GDP during 
estimation21.  
We run different sets of regressions for total, public and private HCE (Table 3-5).  
In line with previous findings in the literature, we identify a positive relationship 
between HCE and GDP. Estimates are obtained both by PMG estimation and by 
instrumental variable (IV) techniques applied to first differences22, explicitly 
dealing with the endogeneity of GDP and non-stationarity of the series. Given the 
                                                 
20
 Carrion-i-Silvestre (2005) provides evidence that HCE and GDP series can be characterized as 
stationary processes evolving around a broken trend. Similar results are reported in Jewell et al. (2003). A 
throughout investigation of the pattern of series stationarity is beyond the scope of this paper and it is 
carried trough only as a preliminary step to the regression analysis. In addition, the empirical size and 
power of the unit root tests largely depend on the available data. Therefore, we prefer employing an 
estimation strategy that is “robust” to stationarity patterns. 
21
 A two-stage approach is considered when estimating the relationship between HCE and GDP. The 
instruments considered for estimation are energy use (kg of oil equivalent per capita) and an index of 
openness, computed as the sum of imports and exports of goods and services (as a share of GDP). Data 
are extracted from the World Bank (World Development Indicators). The validity of the selected 
variables is assessed via the Hansen test.  
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log-log specification of the model, estimated coefficients can be interpreted as the 
elasticity of HCE with respect to income. As for the magnitude of this coefficient, 
both total and public expenditures exhibit an elasticity that is higher than one, 
whereas the estimated elasticity of private expenditure is below the unity23. The 
results add insights to the current debate on the nature of health care. Available 
evidence shows that health care behave as an inferior good at the micro level, 
while becoming a luxury good when data are aggregate at regional, national or 
even global scale. Coherently with these findings, the estimated elasticity of total 
HCE provides empirical support to the luxury good hypothesis, where the impact 
of economic growth on health expenditure passes mainly trough the public 
component. Even though, as previously stressed, the empirical evidence provided 
needs to be treated with caution given the presence of exogenously imposed 
regulation limiting the choices of patients and aggregate HCE (which therefore 
might not represent optimal consumption), this result points directly to the core of 
the sustainability problem. Growth cannot be invoked to stabilize the incidence of 
HCE on GDP and to expand the level of the demand for care. Paradoxically, if 
analysis is confined to the HCE-GDP relationship, lower growth rates would 
rather help. 
Next, we include in our regressions the variables aimed at capturing ageing 
population, technological change, the institutional framework, budget constraints, 
and life habits. When available data allow us, the PMG estimator is applied to per 
capita variables; otherwise we resemble to first difference estimation coupled with 
a two-stage approach (FD-IV). 
If only GDP is taken into account, PMG estimates24 confirm the results of FD-IV 
estimation. On the contrary, by including all other variables the coefficients of 
GDP in total and public HCE regressions decrease below unity. 
                                                                                                                                              
22
 Still country fixed effects are considered, in order to allow for different trends across countries. 
23
 Need it here to stress the fact that, in the countries analyzed, the private component of HCE represents, 
on average, less than 25 per cent of total expenditure. 
24
 Due to the high incidence of missing data, Belgium is excluded from PMG estimation of PHE and 
PrHE. The lag structure of the dependent and independent variable(s) has been chosen on the basis of 
Schwarz Bayesian criterion, where the maximum number of lags is allowed to be equal to 1. 
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Whatever the definition of expenditure (total, public, and private), increased life 
expectancy at age 65 (LEXP65) and decreases in fertility rate (FERTILITY) 
imply higher HCE. Interpreted as the causes at the root of an ageing population, 
the results confirm the fact that ageing population leads to an increase in the level 
of expenditure. It is noticeable that the elasticity of LEXP65 is higher for the 
public component than for the private one. The public component is more exposed 
to the ageing driver, as well to the economic growth driver since private health 
care plays a residual role in most EU countries. 
 
 
Table 3. The determinants of total per capita HCE 
Model FD-IV1 PMG1 PMG2 PMG3 PMG4 FD-IV2 FD-IV3 PMG5 
GDP 1.3202  (0.1640)*** 
1.4653*** 
(0.0699) 
0.7182*** 
(0.0391) 
0.5685*** 
(0.0297) 
0.7226*** 
(0.0375) 
0.7547** 
(0.3782) 
0.7138* 
(0.3719) 
0.9735*** 
(0.0608) 
LEXP65   2.7543*** (0.2873) 
  
 
 
 
FERTILITY   -0.3023*** (0.1176) 
  
 
 
 
TECH_AD    0.0119*** (0.0034) 
 
 
 
 
DCIRC    -0.7395*** (0.0444) 
 
 
 
 
GATE       -0.0124 (0.0087) 
 
COPAY       -0.0162*** (0.0057) 
 
FLPR     1.0422*** (0.0764)   
 
DEBT/GDP 
(lagged) 
     -0.0655* 
(0.0340) 
-0.0662* 
(0.0340) 
 
CONC 
(lagged) 
     0.1110** 
(0.0495) 
0.1196** 
(0.0504) 
 
FVEG      
 
 
0.0110 
(0.0377) 
SUGAR      
 
 
0.3596*** 
(0.0852) 
R-squared 0.3945 n.a. n.a. n.a. n.a. 0.5785 0.5913 n.a. 
N 318 322 302 267 316 206 206 299 
Statistically significant at: *** 1% level; ** 5% level; 10% level. Standard errors in parenthesis.  
 
As far as the “technology” variables, TECH_AD exerts a positive effect on HCE, 
whereas the coefficient of DCIRC is negative, pointing to a positive long-run 
effect of technological change on HCE. Our results support the view that in the 
long run technical change leads to an increase in the aggregate expenditure. Even 
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though the empirical literature provides examples of single new technologies that 
exert both positive and negative effects on health costs, increases in aggregate 
expenditure are expected. However, no account is made in our analysis of the 
benefits associated with medical technology improvements, therefore no 
conclusions can be drawn on the issue of the net value accrued to patients from 
innovation. 
 
Table 4. The determinants of public per capita HCE 
 FD-IV1 PMG1 PMG2 PMG3 PMG4 FD-IV2 FD-IV3 PMG5 
GDP 1.6594  (0.2485)*** 
1.3955*** 
(0.0613) 
0.9268*** 
(0.0541) 
0.8037*** 
(0.0556) 
0.7817*** 
(0.0402) 
0.7733** 
(0.3952) 
0.7594* 
(0.3894) 
1.3974*** 
(0.0602) 
LEXP65   2.0005*** (0.3074) 
  
   
FERTILITY   -0.8542*** (0.2039) 
  
   
TECH_AD    0.0020 (0.0054) 
 
 
  
DCIRC    -0.4418*** (0.0832) 
 
 
  
GATE       -0.0200** (0.0102)  
COPAY       -0.0136* (0.0076)  
FLPR     1.7257*** (0.1166)    
DEBT/GDP 
(lagged) 
     -0.0885* 
(0.0454) 
-0.0898** 
(0.0452)  
CONC 
(lagged) 
     0.1284** 
(0.0586) 
0.1418** 
(0.0616)  
FVEG      
 
 
0.1122 
(0.0750) 
SUGAR      
 
 
0.3887*** 
(0.1032) 
R-squared 0.2556 n.a. n.a. n.a. n.a. 0.5074 0.5202 n.a. 
N 307 298 285 253 296 196 196 275 
Statistically significant at: *** 1% level; ** 5% level; * 10% level. Standard errors in parenthesis. 
 
As expected, a higher rate of female participation rate (FLPR) corresponds to 
higher levels of expenditure. We argue that this is driven by wider reliance on the 
formal assistance provided by the health care system as opposed to informal 
family assistance, leading to higher expenditure. Given the trend of increasing 
FLPR across European countries, the result deserves policy attention in order to 
ensure sustainability of the current trends.  
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Not surprisingly, the GP gatekeeper role effectively decreases the level of public 
HCE (in the case of total HCE, the coefficient is still negative but not statistically 
significant). In addition, the presence of significant hospital and GP co-payment 
(COPAY) exerts a negative effect on all items of HCE.  
 
Table 5. The determinants of private per capita HCE 
 FD-IV1 PMG1 PMG2 PMG3 PMG4 FD-IV2 FD-IV3 PMG5 
GDP 0.4446  (0.3044) 
0.3707*** 
(0.0636) 
0.5890*** 
(0.0489) 
0.5654*** 
(0.0296) 
0.5172*** 
(0.0297) 
0.5272 
(0.4917) 
0.4174 
(0.4854) 
0.3986*** 
(0.0637) 
LEXP65   1.8309*** (0.2218) 
  
   
FERTILITY   0.7745*** (0.1020) 
  
   
TECH_AD    -0.0004  (0.0031) 
 
   
DCIRC    -0.8622*** (0.0480) 
 
   
GATE      
 
0.0053 
(0.0159)  
COPAY      
 
-0.0315* 
(0.0187)  
FLPR     1.0200*** (0.0659)    
DEBT/GDP 
(lagged) 
     0.0455 
(0.0400) 
0.0480 
(0.0390)  
CONC 
(lagged) 
     
0.0465 
(0.0913) 
0.0463 
(0.0898)  
FVEG        -0.0753* (0.0206) 
SUGAR        -0.0162 (0.0725) 
R-squared 0.1606 n.a. n.a. n.a. n.a. 0.4412 0.4501 n.a. 
N 302 298 285 253 296 196 196 275 
Statistically significant at: *** 1% level; ** 5% level; 10% level. Standard errors in parenthesis. 
 
Over time, the design of co-payment schemes has been able to stimulate the 
responsibility by citizens and, through their behaviors, responsibility of all actors 
in the health care system, leading to the beneficial effects in terms of cost 
containment. 
Turning to the budget constraints variables25, DEBT/GDP has a negative impact 
on levels of both total and public HCE, whereas no effect is detected when 
analyzing private expenditure. Highly indebted Countries have to pay relevant 
                                                 
25
 A one-year lag of the variables DEBT/GDP and CONC is considered in the regressions. 
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amounts of resources as passive interests, and so budget constraints inevitably 
become stronger on other balance items that can be more easily compressed. High 
public debt and correspondently high interests payments tie the hands of the 
policy makers, year by year. 
As predicted, the variable aimed at capturing the structure of the social 
expenditure has a positive effect on total and public HCE. The result preludes to 
the view that a wider coverage of the public expenditure across different social 
policy areas (i.e. lower concentration of expenditure, especially on pensions) leads 
to gains in growth, efficiency and welfare diffusion, being strongly interlinked to 
improved social and market labor conditions. Therefore, the results support the 
thesis that a social public expenditure less concentrated on pensions - currently 
the main item in welfare system budgets and the main source of concentration of 
public social expenditure - helps ameliorating the financial sustainability, 
allowing also to channel more resources to those institutions better suited for 
efficient redistribution and to realize the goal of universalistic cohesion.  
Coupled with previous finding of a positive correlation between public deficit 
(%GDP) and social expenditure concentration (Table 1a), the result allows us to 
infer that the enlargement of the functions covered by the public welfare system is 
not financed, on average, out of an increase in public borrowing and public debt, 
but rather thanks to a better functioning of the economic system. Higher 
expenditure and sustainability do not contrast each other, under the appropriate 
design for welfare systems. Another possible confirmation of this virtuous circle 
is provided by the correlation coefficient between GDP growth (real values) and 
the level of concentration of social public expenditure which is always negative 
over the period 1985-2003 (Table 1b). Though preliminary, the negative sign adds 
some evidence in favor of the thesis that a diversified welfare system fosters 
economic growth, and indeed is a source of economic growth and larger 
resources. 
Finally, we consider the effect of life habits, as measured by per capita 
consumption of sugar and fruits and vegetables. As expected, higher consumption 
of sugar is linked to higher levels of expenditure, whereas higher consumption of 
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fruits and vegetables is associated with lower levels of private expenditure (no 
relationship is detected with total and public expenditure). This result is important 
in light of the recent policy actions aimed at promoting a “healthy” life-style 
undertaken in some European countries. 
 
IV. Conclusions  
Even though preliminary in nature, the analyses presented in this paper 
contributes to our understanding of the key driving forces of HCE in Europe. We 
consider multiple factors and incentives, trying to take into account technological 
change, consumer preferences, ageing of the population, life habits, and budgetary 
and institutional variables. 
Income, as measured by GDP levels, is one of the key drivers of HCE, where the 
estimated elasticity provides evidence of public (and total) health being a “luxury 
good”, whereas estimated elasticity for the private component of the expenditure 
is below unity. This is a key point, since HCE projections are highly sensitive to 
assumptions on the elasticity value, and elasticity to income is key for health care 
budget sustainability in the long run and along the business cycle. Confirmation of 
the “luxury good” hypothesis would imply that policy actions to sustain health 
care budget cannot rely on an increase in GDP (leading to a more than 
proportionate increase in HCE), and would provide further support to the 
statement that economic growth cannot be advocated as a way to smooth or 
reduce budgetary controls in the health sector. Even though the result needs to be 
interpreted with caution as observed HCE might not reflect optimal consumption 
(due to the presence of exogenously imposed Government budget constraints), it 
points directly to the core of the sustainability problem. 
Private expenditures are paid out from households income and/or from insurance 
products, and for this reason the level of individual responsibility in consumption 
tends to be constantly high, leading to less than proportionate increases. On the 
contrary, public systems tend to pursue universality through the full/partial 
gratuitousness of provisions, and so encounter difficulties in combining 
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adequacy/equity with efficiency/efficacy (they are exposed to phenomena of over 
consumption, inappropriate consumption, and the so called problem of “the third 
payer” makes it difficult to promote the adoption of best practices by doctors and 
providers).  
Besides GDP, higher life expectancy, female labor participation and decreasing 
fertility rate, contribute to the rising of HCE. Results also stress the importance of 
health habits and technological change in determining differences in the level of 
HCE across countries26. Budget constraints significantly explain the level of 
expenditure, as well as the framework variables. No single recipe exists for 
keeping health care budgets under control, and different countries have applied 
different methods and undertaken different policy actions. Nonetheless the rules 
for accessing medical services, and co-payment systems on citizens exert an effect 
on the level of expenditure.  
All in all, the structural features of health care systems make it difficult to sustain 
the current trend in the long run. On the one side, the effect of technological 
change in the health care sector with respect to the other sectors inexorably lead to 
an increasing share of public finances allocated to health. Hartwig (2008) provides 
an empirical account of the Baumol model of unbalanced growth. The health care 
sector is indeed labor intensive, characterized by negative productivity 
differentials with respect to other goods and services in the economy. The 
equalization of wages across sectors, then, produces the inexorable rise of relative 
prices (Baumol, 1967). Coupled with the crucial role of consumer preferences in 
the growing share of health spending to GDP (Hall and Jones, 2007), the finding 
seems to leave little room for public policy.  
On the contrary, we argue that the finding should drive policy maker’s attention 
towards the burden that this expenditure item will produce on public finances, 
rapidly promoting a political debate at European level aimed at designing those 
structural reforms which are needed to assure long-term sustainability and 
prosperity. A significant fraction of EU health care is tax funded: healthy young 
                                                 
26
 Needless to say, the benefits associated with longer healthy life are not easily accounted for in this type 
of regressions, nonetheless being an important implication of technological progress. 
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workers pay for the care of sick, usually older and poorer citizens. In turn, young 
generations rely on future generations to pay for their care. But demographic 
changes – a falling birth rate, growing life expectancy and increasing female labor 
participation – are likely to cause severe funding problems within the existing 
framework, which will worsen over the years.  
Against this background, we posit that both in Europe and in the US the key 
challenge for Governments is how to design pluralistic systems of health care 
delivery and financing, where a well-balanced mix of public and private financing 
can sustain investment and innovation, without imposing unsustainable burdens 
on public budgets, and without denying care to the disadvantaged population.  
System reforms should be framed within a wide perspective. Health care reforms 
should be accompanied by regulation on supply and demand side; the reform of 
the welfare system structure and of the labor market; the adoption of the 
“selective universalism” perspective; the development of fully founded financing 
schemes based on funds, both for health care and for pensions. Results on the 
CONC variable supports the rationale at the basis of the so called “Lisbon 
agenda”, aiming at reinforcing welfare instruments capable of promoting 
participation to labor market, effective employability - especially for the young, 
women and the old persons (55-64) - and productivity: human capital formation, 
active labor policies, family and children assistance, housing assistance, formal 
assistance for dependants who need long term cares. From this perspective, we 
argue in favor of a change from the traditional welfare perspective to the so called 
workfare perspective, stressing the fact that, in order to implement it, 
Governments have not only to devise structural reforms in their welfare systems, 
but also to accompany them with reforms of the labor market and of the markets 
of goods and services, in the sense of an higher openness to changeover and 
competition. This would be beneficial as would allow financing a sustainable 
redistribution, embedded in a process of general economic growth. 
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